Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Broad details emerge, such as targeting the HIV hot spots that, when combined, account for 50 percent of new HIV cases.
National Institutes of Health (NIH) officials discuss scientific evidence and principles underlying the U=U concept.
The new federal initiative will work with existing research programs in eight cities.
Periodic infusions of such antibodies may eventually become a new way of treating the virus.
The iconic AIDS activist sounded off in a STAT interview—and shared how he’s spending his declining years.
Promising news on the prevention front
It’s the NIH’s first large-scale clinical trial on the subject. Plus: Meet organ transplant advocate Mo Murray [VIDEO].
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.
Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.
A statement from the National Institutes of Health on World AIDS Day 2017.
The study of a vaccine that is designed to prevent multiple strains of the virus will include 2,600 women in sub-Saharan Africa.
HIV scientists and advocates are waging a powerful war against the global epidemic.
A 9-year-old South African child infected with HIV at birth has been in an apparent state of extended viral remission.
A new HIV vaccine regimen was well tolerated and elicited a good immune response among participants of a study who did not have the virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.